Monolithic Power Systems Inc vs Vir Biotechnology Inc. Common Stock — how do they compare? Monolithic Power Systems Inc trades at $1,238 (market cap $64.85B), while Vir Biotechnology Inc. Common Stock trades at $10.2 (market cap $1.80B). The key difference: Monolithic Power Systems Inc is far larger — about 36× Vir Biotechnology Inc. Common Stock's market cap, and Monolithic Power Systems Inc pays a 0.61% dividend while Vir Biotechnology Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Monolithic Power Systems Inc for 25 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| MPWR | VIR | |
|---|---|---|
Market Cap | $64.85B | $1.80B |
Volume | 692,538 | 1,782,836 |
Sector | Technology | Health |
52-Week High | $1.69K | $11.78 |
52-Week Low | $856.96 | $5.12 |
Typical Hold Time | 25 Days | 0 Days |
Enterprise Value | $63.45B | $1.36B |
Dividend Yield | 0.61% | — |
Signals from Pluang's Aura AI — not financial advice
MPWR trades at $1,319.55 with minimal daily movement (+0.02%) amid a bearish technical signal. The stock shows strong fundamentals with consistent earnings beats, 24.5% net margins, and robust revenue growth from $2.8B to $3.3B year-over-year. Recent news highlights CEO share sales and a manufacturing partnership with GlobalFoundries to support AI and data center demand. Valuation remains elevated with P/E at 80.5 and P/S at 19.7, reflecting high growth expectations.
The outlook remains positive given analyst consensus (88% buy ratings) and a $1,830 price target, but risks include premium valuation compression, insider selling, and dependence on AI infrastructure growth. Cash flow strength supports dividend payments, though technical weakness near key support at $1,300 requires monitoring for sustained bullish momentum.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Monolithic Power Systems, Inc. is a global leader in high-performance, analog, and mixed-signal semiconductors. The company specializes in power management solutions, providing integrated circuits (ICs) for a wide range of applications, including computing, automotive, industrial, and communications. MPWR's proprietary process technology is designed to deliver highly energy-efficient and compact power solutions, positioning the company as a key supplier for the next generation of electronic devices.
Read more on MPWR →Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →